Cargando…
Mechanisms of ranolazine's dual protection against atrial and ventricular fibrillation
Coronary artery disease and heart failure carry concurrent risk for atrial fibrillation and life-threatening ventricular arrhythmias. We review evidence indicating that at therapeutic concentrations, ranolazine has potential for dual suppression of these arrhythmias. Mechanisms and clinical implicat...
Autores principales: | Verrier, Richard L., Kumar, Kapil, Nieminen, Tuomo, Belardinelli, Luiz |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3578672/ https://www.ncbi.nlm.nih.gov/pubmed/23220484 http://dx.doi.org/10.1093/europace/eus380 |
Ejemplares similares
-
Pulmonary Delivery of Antiarrhythmic Drugs for Rapid Conversion of New-Onset Atrial Fibrillation
por: Verrier, Richard L., et al.
Publicado: (2020) -
Refractory atrial fibrillation effectively treated with ranolazine
por: Vaishnav, Aditi, et al.
Publicado: (2014) -
Ranolazine for atrial fibrillation: buy one get three beneficial mechanisms!
por: Maier, Lars S.
Publicado: (2012) -
The effect of ranolazine on maintaining sinus rhythm in patients with resistant atrial fibrillation
por: Murdock, David K, et al.
Publicado: (2008) -
Ranolazine in the prevention and treatment of atrial fibrillation: A protocol for meta-analysis
por: Yuan, Chengdai, et al.
Publicado: (2021)